Analystreport

Jazz Pharmaceuticals (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Wells Fargo. They now have a $182.00 price target on the stock, up previously from $176.00.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com